Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
We are seeking a Director of Program Strategy & Management to lead the full lifecycle of strategic programs across Capricor’s therapeutic portfolio. This senior leadership role will oversee cross-functional initiatives spanning R&D, regulatory, operations, and quality, ensuring alignment with corporate goals, timelines, and compliance standards. You will serve as a key partner to executive leadership, driving program execution, risk mitigation, and continuous improvement across the organization. You will also be supported by a dedicated Project Manager who will assist in tactical execution, documentation, and cross-functional coordination.
